What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Surgery
His primary scientific interests are in Internal medicine, Endocrinology, Cardiology, Angiogenesis and Immunology.
His Internal medicine study is mostly concerned with Adiponectin, Endothelium, Heart failure, Ischemia and Nitric oxide.
His Endocrinology research incorporates themes from Inflammation, Receptor and AMPK.
His work deals with themes such as Vascular endothelial growth factor A, Vascular endothelial growth factor and Endothelial stem cell, which intersect with Angiogenesis.
The various areas that Toyoaki Murohara examines in his Immunology study include Progenitor cell, Pharmacology and In vivo.
Toyoaki Murohara interconnects CD34 and Transplantation in the investigation of issues within Progenitor cell.
His most cited work include:
- Isolation of putative progenitor endothelial cells for angiogenesis. (7575 citations)
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. (1538 citations)
- Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction (1111 citations)
What are the main themes of his work throughout his whole career to date?
Toyoaki Murohara mainly investigates Internal medicine, Cardiology, Endocrinology, In patient and Heart failure.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Surgery.
His Cardiology study incorporates themes from Hemodialysis and Hazard ratio.
As part of his studies on Endocrinology, Toyoaki Murohara often connects relevant subjects like Angiogenesis.
He combines subjects such as Endothelial stem cell, Ischemia and Progenitor cell with his study of Angiogenesis.
Percutaneous coronary intervention is closely attributed to Conventional PCI in his study.
He most often published in these fields:
- Internal medicine (71.74%)
- Cardiology (47.39%)
- Endocrinology (21.28%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (71.74%)
- Cardiology (47.39%)
- Heart failure (12.70%)
In recent papers he was focusing on the following fields of study:
Toyoaki Murohara mainly focuses on Internal medicine, Cardiology, Heart failure, In patient and Percutaneous coronary intervention.
His Internal medicine study often links to related topics such as Endocrinology.
His research brings together the fields of Inflammation and Endocrinology.
As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Renal function, and often Kidney disease.
He works in the field of Heart failure, focusing on Cardiac function curve in particular.
Many of his studies on Percutaneous coronary intervention apply to Conventional PCI as well.
Between 2016 and 2021, his most popular works were:
- JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ― (103 citations)
- Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury. (54 citations)
- Role of Adipokines in Cardiovascular Disease. (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cardiology
Internal medicine, Cardiology, Heart failure, Endocrinology and Myocardial infarction are his primary areas of study.
In his articles, Toyoaki Murohara combines various disciplines, including Internal medicine and In patient.
His Cardiology research includes themes of Diabetes mellitus, Diastole and Renal function.
He has included themes like Creatinine and Kidney disease in his Renal function study.
His studies in Endocrinology integrate themes in fields like Inflammation, Receptor and Neointima.
His biological study deals with issues like Coronary artery disease, which deal with fields such as Revascularization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
